ClinicalTrials.Veeva

Menu

Vibrotactile Coordinated Reset in Parkinson's Disease - Proof of Concept Study

Stanford University logo

Stanford University

Status

Not yet enrolling

Conditions

Parkinson Disease

Treatments

Device: Stanford Glove

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

The purpose of our study is to evaluate Vibrotactile Coordinated Reset stimulation (vCR) and its effects on Parkinson's symptoms. vCR will be administered with a device called the Stanford Glove. vCR is expected to provide patients with a non-invasive alternative to the most widely used treatments such as Levodopa and/or deep brain stimulation. Patients will be followed for 14 months.

Full description

The purpose of this study is to test the efficacy of vibrotactile coordinated reset stimulation on human subject participants with Parkinson's disease and inform the investigators on whether unilateral stimulation could be as effective as bilateral stimulation at producing clinically significant improvements in symptoms.

Enrollment

34 estimated patients

Sex

All

Ages

18 to 92 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Ages 18 or older

  • Diagnosed with idiopathic Parkinson's Disease
  • Fluent in English
  • Off-state UPDRS III motor score at least 30, as assessed within the past 6 months before study consent or at Screening Visit.
  • Demonstrates understanding of the study requirements and is able and willing to sign the informed consent form and complete study procedures.

Exclusion criteria

  • Participation in another drug, device, or biologics trial concurrently or within the preceding 30 days. Any other trial participation should be approved by the Principal Investigators.
  • Pregnancy, breast-feeding or wanting to become pregnant
  • Physical limitations unrelated to PD that would affect motor ratings
  • Has implantation of a medical device
  • Sensory abnormalities of the fingertips

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Quadruple Blind

34 participants in 2 patient groups

Active stimulation
Active Comparator group
Description:
Participants will receive active stimulation between 2 hours minimum and 4 hours maximum of daily vCR or sham stimulation (2 hours twice daily) at home for the first month (30 days), followed by a minimum of 1.5 hours and a maximum of 2.5 hours of daily vCR
Treatment:
Device: Stanford Glove
Sham Stimulation
Sham Comparator group
Description:
Participants will receive sham stimulation between 2 hours minimum and 4 hours maximum of daily vCR or sham stimulation (2 hours twice daily) at home for the first month (30 days), followed by a minimum of 1.5 hours and a maximum of 2.5 hours of daily vCR
Treatment:
Device: Stanford Glove

Trial contacts and locations

1

Loading...

Central trial contact

Ellyn Daly; Jessica Yankulova

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems